Statements (52)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:chemical_compound
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:Claritin-D_12_Hour
gptkb:Claritin-D |
| gptkbp:composed_of |
phenylacetone
|
| gptkbp:depicted_in |
controlled substances in some jurisdictions
|
| gptkbp:developed_by |
ephedrine
|
| gptkbp:excretion |
urine
|
| gptkbp:has_genre |
gptkb:battle
|
| gptkbp:has_luminosity |
gptkb:theorem
|
| gptkbp:healthcare |
essential medicines
|
| https://www.w3.org/2000/01/rdf-schema#label |
Pseudoephedrine
|
| gptkbp:ingredients |
C10 H15 NO
|
| gptkbp:interacts_with |
MAO inhibitors
blood pressure medications certain antidepressants |
| gptkbp:is_a |
decongestant
|
| gptkbp:is_associated_with |
methamphetamine production
|
| gptkbp:is_available_in |
various formulations
|
| gptkbp:is_available_on |
liquid form
oral tablet extended-release tablet |
| gptkbp:is_considered |
a precursor chemical
|
| gptkbp:is_part_of |
many OTC products
|
| gptkbp:is_subject_to |
purchase limits in pharmacies
|
| gptkbp:is_used_by |
in many regions
|
| gptkbp:is_used_for |
nasal congestion
hay fever allergic rhinitis sinus pressure relief ear congestion |
| gptkbp:is_used_in |
pain relievers
combination therapies cough syrups allergy medications cold medications flu medications sinus medications |
| gptkbp:lifespan |
5 to 8 hours
|
| gptkbp:mass |
169.24 g/mol
|
| gptkbp:metabolism |
liver
|
| gptkbp:regulates |
some countries
|
| gptkbp:reports_to |
some sports organizations
|
| gptkbp:side_effect |
dizziness
nausea insomnia increased heart rate |
| gptkbp:suitable_for |
pregnant women
children under 4 years old people with high blood pressure people with certain heart conditions |
| gptkbp:type_of |
90-82-4
|